ORPHA:2331
Kawasaki disease
Also known as: Mucocutaneous lymph node syndrome
Publications
21,285
Trials
39
Interventional, condition-specific
Researchers
1,089
Distinct authors in sample
Gene link
—
Readiness
2/6
Stages with a signal
Clinical definition (Orphanet)
A rare inflammatory disease characterized by an acute febrile, systemic, self-limiting, medium-vessel vasculitis primarily affecting children. It often causes acute coronary arteritis which is associated with coronary arterial aneurysms (CAA) that may be life threatening when untreated.
How rare: How common this is has not been clearly measured.
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0012727
- MeSH:D009080
- OMIM:611775
- UMLS:C0026691
- NCIT:C34825
Additional Mondo synonyms (5)
Kawasaki syndrome · acute febrile mucocutaneous lymph node syndrome · acute febrile mucocutaneous lymph node syndrome [MCLS] · infantile polyarteritis nodosa · mucocutaneous lymph node syndrome
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
2/6 stages with a signal
An interventional trial matched this condition name on ClinicalTrials.gov — see trials below.
- Gene identifiedNot found
No GenCC disease–gene assertion in this build
- LiteraturePresent
21,285 matched papers (12,780 in last 10 years) Source
- Phenotype characterisedNot checked
Not yet enriched from Monarch / HPO
- Animal modelNot checked
Not yet enriched from Monarch / Alliance
- Orphan designationNot checked
FDA/EMA orphan-drug designation not enriched yet
- Interventional trialPresent
39 matched on ClinicalTrials.gov (8 recruiting in sample)
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Not yet — the cause hasn't been pinned down in GenCC.
No strong gene–disease assertion joined for this Orphanet entity.
Phenotypes (Monarch / HPO)
Not enriched in this build — Monarch phenotype joins were not run for this record.
Animal models (Monarch / Alliance)
Not enriched in this build.
Literature
Is anyone studying this?
21,285
21,285 papers — among the better-studied rare conditions, though still a fraction of common-disease literature (breast cancer: over 700,000). Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=5449) is 41.
21,285 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 41 (publications denominator n=5449).
12,780 in the last 10 years · low confidence
Phrase hits: 21,285 · MeSH hits: 0
Who's working on it?
1,089
Distinct author names in 200 sampled papers — named people below.
Who's working on it?
People publishing on this condition (sampled Europe PMC records). Affiliation is the most recent found in that sample.
- 01Liu Y10 papers · 2026
Institute of Pediatric Research, Children's Hospital of Soochow University, No. 92 Zhongnan Street, Jiangsu, 215025, Suzhou, China. d201077400@alumni.hust.edu.cn.
Papers in Europe PMC - 02Lv H10 papers · 2026
Department of Cardiology, Children's Hospital of Soochow University, 215025, Suzhou, China.
Papers in Europe PMC - 03Chen Y9 papers · 2026
Department of Pediatrics, The first people's Hospital of Yunnan Province, The Affiliated Hospital of Kunming University of Science and Technology, Kunming 650032, Yunnan, China.
Papers in Europe PMC - 04Li X8 papers · 2026
Department of Pediatrics, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China.
Papers in Europe PMC - 05Liu Z8 papers · 2026
Children's Medical Center, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, China.
Papers in Europe PMC - 06Wang C8 papers · 2026
Department of Pediatrics, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China.
Papers in Europe PMC - 07Wang Y8 papers · 2026
Dr. Neher's Biophysics Laboratory for Innovative Drug Discovery, State Key Laboratory of Quality Research in Chinese Medicine, Faculty of Chinese Medicine, Macau University of Science and Technology, Macau, China.
Papers in Europe PMC - 08Zhang J7 papers · 2026
Department of Pediatrics, Sichuan Academy of Medical Science-Sichuan Provincial People's Hospital, Chengdu, Sichuan, China.
Papers in Europe PMC - 09Liu X6 papers · 2026
Key Laboratory of Birth Defects and Related Diseases of Women and Children of MOE, Department of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China.
Papers in Europe PMC - 10Singh S6 papers · 2026
Allergy and Immunology Unit, Department of Paediatrics, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
Papers in Europe PMC
Clinical research
Is a treatment being tested?
39
interventional trials for this specific condition
39 interventional trials matched this specific condition name; 8 currently recruiting in our sample.
Data as of 27 July 2026
39 interventional trials — more than 73% of diseases in the trials denominator have none at all (5114 of 7003; this disease is at the 96.5th percentile).
low confidence · 96.5th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
39 interventional trials matched after quoted-phrase search and title/condition post-filter.
- NCT04656184·RECRUITING·A Trial Comparing the Efficacy and Safety of Anakinra Versus Intravenous Immunoglobulin (IVIG) Retreatment, in Patients With Kawasaki Disease Who Failed to Respond to Initial Standard IVIG Treatment
Conditions: Kawasaki Disease·Matched via name phrase
- NCT07686770·NOT YET RECRUITING·Efficacy and Safety of Immunoglobulin Plus Firsekibart in Patients With Kawasaki Disease
Conditions: Kawasaki Disease·Matched via name phrase
- NCT07291245·RECRUITING·Kawasaki MATCH Trial
Conditions: Kawasaki Disease·Matched via name phrase
- NCT06697431·NOT YET RECRUITING·Non Inferiority KawasakI Trial With Anakinra
Conditions: Kawasaki Disease · Anakinra·Matched via name phrase
- NCT05643651·RECRUITING·Rivaroxaban for Children Aged Over 2 Years With Giant Coronary Artery Aneurysms After Kawasaki Disease
Conditions: Kawasaki Disease · Coronary Artery Aneurysm·Matched via name phrase
- NCT06775457·RECRUITING·Genome Analysis of Human Endogenous Retroviruses (HERVs)(COVID19)
Conditions: SARS CoV-2 · Kawasaki Disease · Retrovirus Infection·Matched via name phrase
- NCT07530640·RECRUITING·Statins Study in Children of Acute Kawasaki Disease With Coronary Artery Abnormalities
Conditions: Kawasaki Disease · Coronary Artery Abnormalities·Matched via name phrase
- NCT06978439·RECRUITING·Model-informed Dose Optimization for Rivaroxaban in Children With Giant Coronary Artery Aneurysm After Kawasaki Disease
Conditions: Kawasaki Disease · Pilot Study · Coronary Artery Aneurysm · Rivaroxaban·Matched via name phrase
Observational and natural-history studies
24 observational studies match this condition. These do not test a treatment and are not counted in the interventional-trial headline, but they are genuine research: natural-history work often defines the endpoints needed for a future rare-disease trial, and families may be able to enroll.
Recruiting or not-yet-recruiting
- NCT06641817·ENROLLING BY INVITATION·The Value of Cardiovascular Imaging in Kawasaki Disease
Conditions: Kawasaki Disease·Matched via name phrase
- NCT04278404·RECRUITING·Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
Conditions: Coronavirus Infection (COVID-19) · Pulmonary Arterial Hypertension · Urinary Tract Infections in Children · Hypertension·Matched via name phrase
- NCT06993636·RECRUITING·Pharmacometrics Analysis of Rivaroxaban in Chinese Children Aged Over 2 Years
Conditions: Kawasaki Disease · Coronary Artery Aneurysm · Rivaroxaban · Anticoagulant Drugs·Matched via name phrase
- NCT07491926·NOT YET RECRUITING·MASKd: a Study on Kawasaki Disease (KD) Complicated by Macrophage Activation Syndrome (MAS)
Conditions: Kawasaki Disease · Macrophage Activation Syndrome (MAS)·Matched via name phrase
- NCT06641843·ENROLLING BY INVITATION·Magnetic Resonance Myocardial Stress Perfusion in Pediatric Patients with Cardiovascular Disease
Conditions: Kawasaki Disease · Cardiovascular Disease · Anomalous Origin of Coronary Artery·Matched via name phrase
- NCT07086989·RECRUITING·Cardiovascular Risk in Children With Chronic Conditions Study
Conditions: Kidney Transplant · Familial Hypercholesterolaemia · Type 1 Diabetes Mellitus (T1DM) · Type 2 Diabetes Mellitus (T2DM)·Matched via name phrase
- NCT06305611·RECRUITING·European and North Indian Cohort of KaWasaki dIsease
Conditions: Kawasaki Disease·Matched via name phrase
- NCT07405658·NOT YET RECRUITING·Clinical Study on an Artificial Intelligence-Assisted Chest Radiograph Model Based on Big Data and Deep Learning for Early Detection of Kawasaki Disease
Conditions: Kawasaki Disease · Chest X-ray for Clinical Evaluation · Mucocutaneous Lymph Node Syndrome·Matched via name phrase
General rare disease registries you may be eligible for
These studies enroll across many rare conditions. They are not counted as evidence that anyone is studying this specific disease.
- NCT01793168·RECRUITING·Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Conditions: Rare Disorders · Undiagnosed Disorders · Disorders of Unknown Prevalence · Cornelia De Lange Syndrome
Where to find support
We do not yet link condition-specific patient organisations. These umbrella groups support undiagnosed and ultra-rare families:
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
"Kawasaki disease" OR "Mucocutaneous lymph node syndrome" OR "Kawasaki syndrome" OR "acute febrile mucocutaneous lymph node syndrome" OR "acute febrile mucocutaneous lymph node syndrome [MCLS]" OR "infantile polyarteritis nodosa"
ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"Kawasaki disease" OR "Mucocutaneous lymph node syndrome" OR "Kawasaki syndrome" OR "acute febrile mucocutaneous lymph node syndrome" OR "acute febrile mucocutaneous lymph node syndrome [MCLS]" OR "infantile polyarteritis nodosa"
Interventional trials matched via: phrase (mesh = registered under a MeSH descriptor no name phrase would catch; recall-expansion = gene / selected parent terms used only for trials).
Study-type breakdown: 39 interventional · 24 observational · 0 expanded access. Only interventional studies enter the trial headline.
Query health: ok — strategies attempted: phrase; with hits: phrase
Run this search on ClinicalTrials.gov
Confidence reasoning
- Preferred label is short or not clearly distinctive
- No synonyms dropped by stoplist
- No label/synonym collisions with other diseases in this corpus
- Publication count (21285) is extremely high with unknown/missing prevalence — treat as possible over-matching, not proven research intensity
Ingested 2026-07-26T19:53:15.074Z
